Loading company…
Shenzhen Zhongke Xinjin develops peptide drugs for NASH, weight loss and metabolic diseases.
Founded in 2021 in Shenzhen, China, Shenzhen Zhongke Xinjin Biotechnology develops peptide drugs. Its founders are Professor Peigen Ren of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and Liangzheng Qin. The company has product lines for non-alcoholic steatohepatitis and weight loss, and planned to pursue NMPA and FDA investigational new drug applications in 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Shenzhen Zhongke Xinjin Biotechnology? This is my company